Skip to main navigation Skip to search Skip to main content

URINARY PROTEOMICS IN RENAL CELL CANCER BY MALDI-TOF MASS SPECTROMETRY:A PRELIMINARY CONTROLLED STUDY

  • Mario Gardi
  • , Chiara Fanali
  • , Sm Recupero
  • , Federica Iavarone
  • , Antonio Destito
  • , Matteo Vittori
  • , Andrea Volpe
  • , Enrico Sacco
  • , Francesco Pinto
  • , R Inziatari
  • , M Dal Bianco
  • , L De Zorzi
  • , Massimo Castagnola
  • , Pf Bassi

Research output: Contribution to journalArticle

Abstract

Introduction & Objectives: Renal cell cancer (RCC) substantially lacks of biomarkers to assist clinicians in diagnosis, prognosis and response to therapy. Recent studies have demonstrated that the urinary proteome or peptidome is more complex than expected. The aim of this study is to compare the peptidomic profile of urine from RCC patients and healthy controls defined by Mass Spectrometr
Original languageEnglish
Pages (from-to)233-233
Number of pages1
JournalEUROPEAN UROLOGY. SUPPLEMENTS
Volume10
Publication statusPublished - 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • RENAL

Fingerprint

Dive into the research topics of 'URINARY PROTEOMICS IN RENAL CELL CANCER BY MALDI-TOF MASS SPECTROMETRY:A PRELIMINARY CONTROLLED STUDY'. Together they form a unique fingerprint.

Cite this